Navigating tariffs and diplomacy: the future of India-US pharmaceutical trade
The goal is to take annual bilateral trade to $500 billion by 2030 from the current $190 billion.
Pricing and Market Access
The European Market Access Lag: 2021–2024
Trump revives plan for IRP use in US via MFN executive order
Next-generation targeting for evolving HCP engagement
Pharma faces 30-day deadline under Trump’s pricing order
Trump to sign order tying US drug prices to global rates
5EU Q1 2024 versus 2025: Pricing shifts, HTA outcomes, and innovative drug trends
First two medicinal products to undergo EU joint clinical assessments announced
